Patrick P.C. Boor

2.9k total citations
47 papers, 2.1k citations indexed

About

Patrick P.C. Boor is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Patrick P.C. Boor has authored 47 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 20 papers in Oncology and 9 papers in Epidemiology. Recurrent topics in Patrick P.C. Boor's work include Immune Cell Function and Interaction (23 papers), Immunotherapy and Immune Responses (23 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Patrick P.C. Boor is often cited by papers focused on Immune Cell Function and Interaction (23 papers), Immunotherapy and Immune Responses (23 papers) and Cancer Immunotherapy and Biomarkers (13 papers). Patrick P.C. Boor collaborates with scholars based in Netherlands, United States and Poland. Patrick P.C. Boor's co-authors include Jaap Kwekkeboom, Shanta Mancham, Dave Sprengers, Guoying Zhou, Jan N.M. IJzermans, Jacques J. M. van Dongen, Marco J. Bruno, Qiuwei Pan, Anton W. Langerak and Ingrid L. M. Wolvers‐Tettero and has published in prestigious journals such as The Lancet, Blood and Gastroenterology.

In The Last Decade

Patrick P.C. Boor

47 papers receiving 2.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Patrick P.C. Boor Netherlands	26	1.1k	1.0k	430	334	267	47	2.1k
Michael Cruise United States	20	559 0.5×	1.5k 1.5×	787 1.8×	291 0.9×	549 2.1×	51	2.5k
Patrizia Leone Italy	27	711 0.6×	723 0.7×	211 0.5×	675 2.0×	94 0.4×	65	2.0k
Meng-Fen Wu United States	24	642 0.6×	1.9k 1.8×	211 0.5×	679 2.0×	308 1.2×	43	2.6k
Carlos Alfaro Spain	28	2.1k 1.9×	2.2k 2.2×	231 0.5×	726 2.2×	184 0.7×	57	3.7k
Bertrand Huard Switzerland	33	3.3k 2.9×	1.7k 1.6×	309 0.7×	630 1.9×	174 0.7×	68	4.5k
Shanta Mancham Netherlands	21	937 0.8×	743 0.7×	112 0.3×	230 0.7×	215 0.8×	39	1.6k
Bettina Fabiani France	27	619 0.5×	991 1.0×	1.4k 3.2×	318 1.0×	539 2.0×	84	2.5k
Diana F. Hausman United States	18	472 0.4×	584 0.6×	126 0.3×	538 1.6×	91 0.3×	40	1.6k
Andreas Petzer Austria	26	879 0.8×	946 0.9×	157 0.4×	977 2.9×	174 0.7×	111	3.3k
R. Raab Germany	12	460 0.4×	922 0.9×	178 0.4×	363 1.1×	472 1.8×	20	1.7k

Countries citing papers authored by Patrick P.C. Boor

Since Specialization

Citations

This map shows the geographic impact of Patrick P.C. Boor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick P.C. Boor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick P.C. Boor more than expected).

Fields of papers citing papers by Patrick P.C. Boor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick P.C. Boor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick P.C. Boor. The network helps show where Patrick P.C. Boor may publish in the future.

Co-authorship network of co-authors of Patrick P.C. Boor

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick P.C. Boor. A scholar is included among the top collaborators of Patrick P.C. Boor based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick P.C. Boor. Patrick P.C. Boor is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Yan, Li Zhu, Xiaomei Zhuang, et al.. (2024). Unlocking the therapeutic potential of the NKG2A-HLA-E immune checkpoint pathway in T cells and NK cells for cancer immunotherapy. Journal for ImmunoTherapy of Cancer. 12(10). e009934–e009934. 19 indexed citations

Boor, Patrick P.C., Lisanne Noordam, Robert J. de Knegt, et al.. (2022). Current Tolerance-Associated Peripheral Blood Gene Expression Profiles After Liver Transplantation Are Influenced by Immunosuppressive Drugs and Prior Cytomegalovirus Infection. Frontiers in Immunology. 12. 738837–738837. 4 indexed citations

Zhou, Guoying, Ruby Lieshout, Gilles van Tienderen, et al.. (2022). Modelling immune cytotoxicity for cholangiocarcinoma with tumour-derived organoids and effector T cells. British Journal of Cancer. 127(4). 649–660. 63 indexed citations

Zhou, Guoying, Dave Sprengers, Shanta Mancham, et al.. (2019). Reduction of immunosuppressive tumor microenvironment in cholangiocarcinoma by ex vivo targeting immune checkpoint molecules. Journal of Hepatology. 71(4). 753–762. 88 indexed citations

Boor, Patrick P.C., Khe T. C. Tran, Luc J. W. van der Laan, et al.. (2019). Characterization of Antigen-Presenting Cell Subsets in Human Liver-Draining Lymph Nodes. Frontiers in Immunology. 10. 441–441. 10 indexed citations

Zhou, Guoying, Lisanne Noordam, Dave Sprengers, et al.. (2018). Blockade of LAG3 enhances responses of tumor-infiltrating T cells in mismatch repair-proficient liver metastases of colorectal cancer. OncoImmunology. 7(7). e1448332–e1448332. 64 indexed citations

Sideras, Kostandinos, Katharina Biermann, Joanne Verheij, et al.. (2017). PD-L1, Galectin-9 and CD8⁺ tumor-infiltrating lymphocytes are associated with survival in hepatocellular carcinoma. OncoImmunology. 6(2). e1273309–e1273309. 115 indexed citations

Zhou, Guoying, Dave Sprengers, Patrick P.C. Boor, et al.. (2017). Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas. Gastroenterology. 153(4). 1107–1119.e10. 328 indexed citations

Boor, Patrick P.C., Petra E. de Ruiter, Patrick S. Asmawidjaja, et al.. (2016). JAK-inhibitor tofacitinib suppresses interferon alfa production by plasmacytoid dendritic cells and inhibits arthrogenic and antiviral effects of interferon alfa. Translational research. 188. 67–79. 37 indexed citations

10.

Pedroza‐González, Alexander, Guoying Zhou, Simar Pal Singh, et al.. (2015). GITR engagement in combination with CTLA-4 blockade completely abrogates immunosuppression mediated by human liver tumor-derived regulatory T cellsex vivo. OncoImmunology. 4(12). e1051297–e1051297. 52 indexed citations

11.

Boor, Patrick P.C., et al.. (2011). Human plasmacytoid dendritic cells induce CD8⁺LAG‐3⁺Foxp3⁺CTLA‐4⁺ regulatory T cells that suppress allo‐reactive memory T cells. European Journal of Immunology. 41(6). 1663–1674. 43 indexed citations

12.

Metselaar, Herold J., Nicole M. van Besouw, Shanta Mancham, et al.. (2009). Migration of allosensitizing donor myeloid dendritic cells into recipients after liver transplantation. Liver Transplantation. 16(1). 12–22. 14 indexed citations

13.

Linde, K, Patrick P.C. Boor, Jeanine J. Houwing‐Duistermaat, et al.. (2007). CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies. European Journal of Gastroenterology & Hepatology. 19(6). 449–459. 25 indexed citations

14.

Boor, Patrick P.C., Herold J. Metselaar, Shanta Mancham, et al.. (2006). Prednisolone Suppresses the Function and Promotes Apoptosis of Plasmacytoid Dendritic Cells. American Journal of Transplantation. 6(10). 2332–2341. 55 indexed citations

15.

Boor, Patrick P.C., Jan N.M. IJzermans, Renate G. van der Molen, et al.. (2005). Immunomagnetic selection of functional dendritic cells from human lymph nodes. Immunology Letters. 99(2). 162–168. 8 indexed citations

16.

Reuver, Philip de, Vera Pravica, Wim C.J. Hop, et al.. (2003). Recipient CTLA-4 +49 G/G Genotype Is Associated with Reduced Incidence of Acute Rejection After Liver Transplantation. American Journal of Transplantation. 3(12). 1587–1594. 35 indexed citations

17.

Linde, K, Patrick P.C. Boor, Jeanine J. Houwing‐Duistermaat, et al.. (2003). Card15 and Crohn's Disease: Healthy Homozygous Carriers of the 3020insC Frameshift Mutation. The American Journal of Gastroenterology. 98(3). 613–617. 35 indexed citations

18.

Langerak, Anton W., Ingrid L. M. Wolvers‐Tettero, Patrick P.C. Boor, et al.. (2001). Molecular and flow cytometric analysis of the Vβ repertoire for clonality assessment in mature TCRαβ T-cell proliferations. Blood. 98(1). 165–173. 170 indexed citations

19.

Westerman, Anne Marie, Mark M. Entius, Patrick P.C. Boor, et al.. (1999). Novel mutations in theLKB1/STK11 gene in Dutch Peutz-Jeghers families. Human Mutation. 13(6). 476–481. 63 indexed citations

20.

Westerman, Anne Marie, Mark M. Entius, Patrick P.C. Boor, et al.. (1999). Peutz-Jeghers syndrome: 78-year follow-up of the original family. The Lancet. 353(9160). 1211–1215. 98 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact